With Celgene Acquisition Closed, Bristol Faces Major Milestones

 
• By Mandy Jackson
Business teamwork puzzle pieces.
The $76bn merger adds significantly to Bristol's late-stage R&D pipeline. • Source: Shutterstock

More from Deals

More from Business